Clinical Trial Update: Megestrol in Treating Patients With Endometrial Neoplasia or Endometrial Hyperplasia [Phase 2]

View source ↗

Summary

Phase 2 trial of megestrol in endometrial neoplasia or endometrial hyperplasia was terminated; results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Hyperplasia
• Endometrial Neoplasia
• High Grade Squamous Intraepithelial Lesion of the Uterus
• Uterine Corpus Cancer

Drugs mentioned

• megestrol (megestrol)

Snippet

Sponsor: Gynecologic Oncology Group | Conditions: High Grade Squamous Intraepithelial Neoplasia, Stage 0 Uterine Corpus Cancer | Phase 2 | Status: TERMINATED | Results posted: 2020-10-14